Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.77
-0.0700-1.20%
Post-market: 5.67-0.1000-1.73%19:59 EST
Volume:936.49K
Turnover:5.41M
Market Cap:312.64M
PE:-1.60
High:6.06
Open:5.81
Low:5.61
Close:5.84
Loading ...

U.S. RESEARCH ROUNDUP- Arcutis Biotherapeutics, Artiva Biotherapeutics, Nuvalent

Reuters
·
30 Dec 2024

Emergent BioSolutions initiated with a Buy at H.C. Wainwright

TIPRANKS
·
30 Dec 2024

Emergent Stock Skyrockets 251% YTD: How to Play the Stock?

Zacks
·
27 Dec 2024

BUZZ-COMMENT-USD/JPY's rapid rise alarms Japan, a key level overcome

Reuters
·
20 Dec 2024

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live
·
17 Dec 2024

Emergent BioSolutions Wins $50 Million Contract Option for Cyfendus; Shares Rise

MT Newswires Live
·
17 Dec 2024

BRIEF-Emergent Biosolutions Receives $50 Million Contract Option From Barda To Procure Doses Of Cyfendus®

Reuters
·
16 Dec 2024

Emergent BioSolutions receives $50M contract option from BARDA

TIPRANKS
·
16 Dec 2024

Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)

THOMSON REUTERS
·
16 Dec 2024

Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025

THOMSON REUTERS
·
16 Dec 2024

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GlobeNewswire
·
16 Dec 2024

BlueOne Card Expands with Millennium EBS Acquisition

TIPRANKS
·
14 Dec 2024

DEXIS Attends ADF, Showcases Award-Winning Solutions

ACCESSWIRE
·
28 Nov 2024

Envista Announces Release of 2023 Sustainability Report

PR Newswire
·
21 Nov 2024

Envista Announces Participation in Evercore HealthCONx Conference

PR Newswire
·
20 Nov 2024

First mpox case linked to African outbreak reported in U.S.

seekingalpha
·
17 Nov 2024